Antiviral .interferon alfa
(Peginterferon alfa - 2a)
11
To display the price of
Pegasys 180mcg/ml prefilled syringe
please click below
👇 👇 👇
Active substance/Scientific name of Pegasys 180mcg/ml prefilled syringe :
Peginterferon alfa - 2a
About active substance / Uses / Indications (General information):
Indication for treatment of hairy cell leukemia malignant melanoma and aids-related kaposi s sarcoma. mechanism of action interferon alpha binds to type i interferon receptors (ifnar1 and ifnar2c) which upon dimerization activate two jak (janus kinase) tyrosine kinases (jak1 and tyk2). these transphosphorylate themselves and phosphorylate the receptors. the phosphorylated infar receptors then bind to stat1 and stat2 (signal transducers and activators of transcription) which dimerize and activate multiple (~100) immunomodulatory and antiviral proteins. interferon alpha binds less stably to type i interferon receptors than interferon beta.
Company / Production of Pegasys 180mcg/ml prefilled syringe :
F.hoffman la roche > multipharma
Pharmacology / Uses of Pegasys 180mcg/ml prefilled syringe :
Antiviral .interferon alfa
Route of administration of Pegasys 180mcg/ml prefilled syringe :
Injection
Some other medications with the same active substance and uses (Similar products/medicines):
No | Med. | Price | Views |
---|---|---|---|
1 | Reiferon retard 160mcg/1.2ml vial Peginterferon alfa - 2a | 370 L.E. | 13 |
2 | Pegasys 180mcg/ml prefilled syringe Peginterferon alfa - 2a | 1080 L.E. | 12 |
Click to display all drugs/medications for this use/category